A citation-based method for searching scientific literature

Y Gong, R B Slee, N Fukai, G Rawadi, S Roman-Roman, A M Reginato, H Wang, T Cundy, F H Glorieux, D Lev, M Zacharin, K Oexle, J Marcelino, W Suwairi, S Heeger, G Sabatakos, S Apte, W N Adkins, J Allgrove, M Arslan-Kirchner, J A Batch, P Beighton, G C Black, R G Boles, L M Boon, C Borrone, H G Brunner, G F Carle, B Dallapiccola, A De Paepe, B Floege, M L Halfhide, B Hall, R C Hennekam, T Hirose, A Jans, H Jüppner, C A Kim, K Keppler-Noreuil, A Kohlschuetter, D LaCombe, M Lambert, E Lemyre, T Letteboer, L Peltonen, R S Ramesar, M Romanengo, H Somer, E Steichen-Gersdorf, B Steinmann, B Sullivan, A Superti-Furga, W Swoboda, M J van den Boogaard, W Van Hul, M Vikkula, M Votruba, B Zabel, T Garcia, R Baron, B R Olsen, M L Warman. Cell 2001
Times Cited: 1558







List of co-cited articles
957 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High bone density due to a mutation in LDL-receptor-related protein 5.
Lynn M Boyden, Junhao Mao, Joseph Belsky, Lyle Mitzner, Anita Farhi, Mary A Mitnick, Dianqing Wu, Karl Insogna, Richard P Lifton. N Engl J Med 2002
33

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.
Randall D Little, John P Carulli, Richard G Del Mastro, Josée Dupuis, Mark Osborne, Colleen Folz, Susan P Manning, Pamela M Swain, Shan-Chuan Zhao, Brenda Eustace,[...]. Am J Hum Genet 2002
891
23

WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta.
Christine M Laine, Kyu Sang Joeng, Philippe M Campeau, Riku Kiviranta, Kati Tarkkonen, Monica Grover, James T Lu, Minna Pekkinen, Maija Wessman, Terhi J Heino,[...]. N Engl J Med 2013
222
21


Mutations in WNT1 cause different forms of bone fragility.
Katharina Keupp, Filippo Beleggia, Hülya Kayserili, Aileen M Barnes, Magdalena Steiner, Oliver Semler, Björn Fischer, Gökhan Yigit, Claudia Y Janda, Jutta Becker,[...]. Am J Hum Genet 2013
170
18

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.
Masaki Kato, Millan S Patel, Regis Levasseur, Ivan Lobov, Benny H-J Chang, Donald A Glass, Christine Hartmann, Lan Li, Tae-Ho Hwang, Cory F Brayton,[...]. J Cell Biol 2002
806
16

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.
Xiaofeng Li, Yazhou Zhang, Heeseog Kang, Wenzhong Liu, Peng Liu, Jianghong Zhang, Stephen E Harris, Dianqing Wu. J Biol Chem 2005
880
15

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).
W Balemans, M Ebeling, N Patel, E Van Hul, P Olson, M Dioszegi, C Lacza, W Wuyts, J Van Den Ende, P Willems,[...]. Hum Mol Genet 2001
769
15

Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.
W Balemans, N Patel, M Ebeling, E Van Hul, W Wuyts, C Lacza, M Dioszegi, F G Dikkers, P Hildering, P J Willems,[...]. J Med Genet 2002
482
15

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.
M E Brunkow, J C Gardner, J Van Ness, B W Paeper, B R Kovacevich, S Proll, J E Skonier, L Zhao, P J Sabo, Y Fu,[...]. Am J Hum Genet 2001
663
13

Mutations in WNT1 are a cause of osteogenesis imperfecta.
Somayyeh Fahiminiya, Jacek Majewski, John Mort, Pierre Moffatt, Francis H Glorieux, Frank Rauch. J Med Genet 2013
126
12

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Donald A Glass, Peter Bialek, Jong Deok Ahn, Michael Starbuck, Millan S Patel, Hans Clevers, Mark M Taketo, Fanxin Long, Andrew P McMahon, Richard A Lang,[...]. Dev Cell 2005
12

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.
Karol Estrada, Unnur Styrkarsdottir, Evangelos Evangelou, Yi-Hsiang Hsu, Emma L Duncan, Evangelia E Ntzani, Ling Oei, Omar M E Albagha, Najaf Amin, John P Kemp,[...]. Nat Genet 2012
759
12

WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta.
Shawna M Pyott, Thao T Tran, Dru F Leistritz, Melanie G Pepin, Nancy J Mendelsohn, Renee T Temme, Bridget A Fernandez, Solaf M Elsayed, Ezzat Elsobky, Ishwar Verma,[...]. Am J Hum Genet 2013
139
11


SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.
Mikhail Semënov, Keiko Tamai, Xi He. J Biol Chem 2005
517
11

Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis.
Kyu Sang Joeng, Yi-Chien Lee, Joohyun Lim, Yuqing Chen, Ming-Ming Jiang, Elda Munivez, Catherine Ambrose, Brendan H Lee. J Clin Invest 2017
93
11

Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy.
Johane Robitaille, Marcia L E MacDonald, Ajamete Kaykas, Laird C Sheldahl, Jutta Zeisler, Marie-Pierre Dubé, Lin-Hua Zhang, Roshni R Singaraja, Duane L Guernsey, Binyou Zheng,[...]. Nat Genet 2002
329
10

Lrp5 functions in bone to regulate bone mass.
Yajun Cui, Paul J Niziolek, Bryan T MacDonald, Cassandra R Zylstra, Natalia Alenina, Daniel R Robinson, Zhendong Zhong, Susann Matthes, Christina M Jacobsen, Ronald A Conlon,[...]. Nat Med 2011
299
10

Wnt/beta-catenin signaling: components, mechanisms, and diseases.
Bryan T MacDonald, Keiko Tamai, Xi He. Dev Cell 2009
10

Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair.
Qiang Xu, Yanshu Wang, Alain Dabdoub, Philip M Smallwood, John Williams, Chad Woods, Matthew W Kelley, Li Jiang, William Tasman, Kang Zhang,[...]. Cell 2004
582
10

WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk.
Hou-Feng Zheng, Jon H Tobias, Emma Duncan, David M Evans, Joel Eriksson, Lavinia Paternoster, Laura M Yerges-Armstrong, Terho Lehtimäki, Ulrica Bergström, Mika Kähönen,[...]. PLoS Genet 2012
167
10

Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.
Theo P Hill, Daniela Später, Makoto M Taketo, Walter Birchmeier, Christine Hartmann. Dev Cell 2005
783
10

The Wnt signaling pathway in development and disease.
Catriona Y Logan, Roel Nusse. Annu Rev Cell Dev Biol 2004
9

Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.
Liesbeth Van Wesenbeeck, Erna Cleiren, Jeppe Gram, Rodney K Beals, Olivier Bénichou, Domenico Scopelliti, Lyndon Key, Tara Renton, Cindy Bartels, Yaoqin Gong,[...]. Am J Hum Genet 2003
390
9

LDL-receptor-related proteins in Wnt signal transduction.
K Tamai, M Semenov, Y Kato, R Spokony, C Liu, Y Katsuyama, F Hess, J P Saint-Jeannet, X He. Nature 2000
984
9

An atlas of genetic influences on osteoporosis in humans and mice.
John A Morris, John P Kemp, Scott E Youlten, Laetitia Laurent, John G Logan, Ryan C Chai, Nicholas A Vulpescu, Vincenzo Forgetta, Aaron Kleinman, Sindhu T Mohanty,[...]. Nat Genet 2019
210
9

Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.
Heini Hartikka, Outi Mäkitie, Minna Männikkö, Andrea S Doria, Alan Daneman, William G Cole, Leena Ala-Kokko, Etienne B Sochett. J Bone Miner Res 2005
118
9

Osteogenesis imperfecta.
Joan C Marini, Antonella Forlino, Hans Peter Bächinger, Nick J Bishop, Peter H Byers, Anne De Paepe, Francois Fassier, Nadja Fratzl-Zelman, Kenneth M Kozloff, Deborah Krakow,[...]. Nat Rev Dis Primers 2017
237
9



Romosozumab in postmenopausal women with low bone mineral density.
Michael R McClung, Andreas Grauer, Steven Boonen, Michael A Bolognese, Jacques P Brown, Adolfo Diez-Perez, Bente L Langdahl, Jean-Yves Reginster, Jose R Zanchetta, Scott M Wasserman,[...]. N Engl J Med 2014
649
8

Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling.
Bingyu Mao, Wei Wu, Gary Davidson, Joachim Marhold, Mingfa Li, Bernard M Mechler, Hajo Delius, Dana Hoppe, Peter Stannek, Carmen Walter,[...]. Nature 2002
767
8

Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.
Sofia Movérare-Skrtic, Petra Henning, Xianwen Liu, Kenichi Nagano, Hiroaki Saito, Anna E Börjesson, Klara Sjögren, Sara H Windahl, Helen Farman, Bert Kindlund,[...]. Nat Med 2014
183
8

Regulation of osteoblastogenesis and bone mass by Wnt10b.
Christina N Bennett, Kenneth A Longo, Wendy S Wright, Larry J Suva, Timothy F Lane, Kurt D Hankenson, Ormond A MacDougald. Proc Natl Acad Sci U S A 2005
608
8

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis.
Kenneth G Saag, Jeffrey Petersen, Maria Luisa Brandi, Andrew C Karaplis, Mattias Lorentzon, Thierry Thomas, Judy Maddox, Michelle Fan, Paul D Meisner, Andreas Grauer. N Engl J Med 2017
416
8

Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
Johanna Korvala, Harald Jüppner, Outi Mäkitie, Etienne Sochett, Dirk Schnabel, Stefano Mora, Cynthia F Bartels, Matthew L Warman, Donald Deraska, William G Cole,[...]. BMC Med Genet 2012
62
12

Osteogenesis imperfecta.
Antonella Forlino, Joan C Marini. Lancet 2016
385
8

LRP6 mutation in a family with early coronary disease and metabolic risk factors.
Arya Mani, Jayaram Radhakrishnan, He Wang, Alaleh Mani, Mohammad-Ali Mani, Carol Nelson-Williams, Khary S Carew, Shrikant Mane, Hossein Najmabadi, Dan Wu,[...]. Science 2007
417
7

Familial exudative vitreoretinopathy.
V G Criswick, C L Schepens. Am J Ophthalmol 1969
295
7

Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow.
A Bafico, G Liu, A Yaniv, A Gazit, S A Aaronson. Nat Cell Biol 2001
594
7

Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6.
Sheri L Holmen, Troy A Giambernardi, Cassandra R Zylstra, Bree D Buckner-Berghuis, James H Resau, J Fred Hess, Vaida Glatt, Mary L Bouxsein, Minrong Ai, Matthew L Warman,[...]. J Bone Miner Res 2004
258
7

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.
Kazuhisa Nakashima, Xin Zhou, Gary Kunkel, Zhaoping Zhang, Jian Min Deng, Richard R Behringer, Benoit de Crombrugghe. Cell 2002
7

Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
Felicia Cosman, Daria B Crittenden, Jonathan D Adachi, Neil Binkley, Edward Czerwinski, Serge Ferrari, Lorenz C Hofbauer, Edith Lau, E Michael Lewiecki, Akimitsu Miyauchi,[...]. N Engl J Med 2016
565
7

Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling.
Bryan T MacDonald, Xi He. Cold Spring Harb Perspect Biol 2012
291
7


The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations.
Kyu Sang Joeng, Yi-Chien Lee, Ming-Ming Jiang, Terry K Bertin, Yuqing Chen, Annie M Abraham, Hao Ding, Xiaohong Bi, Catherine G Ambrose, Brendan H Lee. Hum Mol Genet 2014
46
15

High bone mass in mice expressing a mutant LRP5 gene.
Philip Babij, Weiguang Zhao, Clayton Small, Yogendra Kharode, Paul J Yaworsky, Mary L Bouxsein, Padmalatha S Reddy, Peter V N Bodine, John A Robinson, Bheem Bhat,[...]. J Bone Miner Res 2003
380
7


Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis.
John P Kemp, John A Morris, Carolina Medina-Gomez, Vincenzo Forgetta, Nicole M Warrington, Scott E Youlten, Jie Zheng, Celia L Gregson, Elin Grundberg, Katerina Trajanoska,[...]. Nat Genet 2017
188
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.